Literature DB >> 15761415

Antimicrobial peptides.

Arash Izadpanah1, Richard L Gallo.   

Abstract

Antimicrobial peptides (AMPs) are small molecular weight proteins with broad spectrum antimicrobial activity against bacteria, viruses, and fungi. These evolutionarily conserved peptides are usually positively charged and have both a hydrophobic and hydrophilic side that enables the molecule to be soluble in aqueous environments yet also enter lipid-rich membranes. Once in a target microbial membrane, the peptide kills target cells through diverse mechanisms. Cathelicidins and defensins are major groups of epidermal AMPs. Decreased levels of these peptides have been noted for patients with atopic dermatitis and Kostmann's syndrome, a congenital neutropenia. In addition to important antimicrobial properties, growing evidence indicates that AMPs alter the host immune response through receptor-dependent interactions. AMPs have been shown to be important in such diverse functions as angiogenesis, wound healing, and chemotaxis. As our knowledge of AMP biology expands, the precise role and relevance of these peptides will be better elucidated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761415     DOI: 10.1016/j.jaad.2004.08.026

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  85 in total

Review 1.  Bacterial persister cell formation and dormancy.

Authors:  Thomas K Wood; Stephen J Knabel; Brian W Kwan
Journal:  Appl Environ Microbiol       Date:  2013-09-13       Impact factor: 4.792

Review 2.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

Review 3.  Bacterial resistance mechanisms against host defense peptides.

Authors:  Tomaz Koprivnjak; Andreas Peschel
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

Review 4.  Adaptation to Adversity: the Intermingling of Stress Tolerance and Pathogenesis in Enterococci.

Authors:  Anthony O Gaca; José A Lemos
Journal:  Microbiol Mol Biol Rev       Date:  2019-07-17       Impact factor: 11.056

5.  Synthesis of a New Peptide-Coumarin Conjugate: A Potential Agent against Cryptococcosis.

Authors:  Soraya Z Ferreira; Hellem C Carneiro; Hugo A Lara; Rosemeire B Alves; Jarbas M Resende; Heloísa M Oliveira; Luciana M Silva; Daniel A Santos; Rossimiriam P Freitas
Journal:  ACS Med Chem Lett       Date:  2015-01-07       Impact factor: 4.345

6.  Analogs of the Cathelicidin-Derived Antimicrobial Peptide PMAP-23 Exhibit Improved Stability and Antibacterial Activity.

Authors:  Yongqing Liu; Tengfei Shen; Liangliang Chen; Jiangfei Zhou; Chen Wang
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

7.  Findings on the interaction of the antimicrobial peptide cecropin-melittin with a gold surface from molecular dynamics studies.

Authors:  André F Ferreira; Akhilesh Rai; Lino Ferreira; Pedro N Simões
Journal:  Eur Biophys J       Date:  2016-07-28       Impact factor: 1.733

8.  Antimicrobial metallopeptides with broad nuclease and ribonuclease activity.

Authors:  Jeff C Joyner; W F Hodnick; Ada S Cowan; Deepika Tamuly; Rachel Boyd; J A Cowan
Journal:  Chem Commun (Camb)       Date:  2013-02-05       Impact factor: 6.222

9.  Eurocin, a new fungal defensin: structure, lipid binding, and its mode of action.

Authors:  Jesper S Oeemig; Carina Lynggaard; Daniel H Knudsen; Frederik T Hansen; Kent D Nørgaard; Tanja Schneider; Brian S Vad; Dorthe H Sandvang; Line A Nielsen; Søren Neve; Hans-Henrik Kristensen; Hans-Georg Sahl; Daniel E Otzen; Reinhard Wimmer
Journal:  J Biol Chem       Date:  2012-10-23       Impact factor: 5.157

10.  Antimicrobial Polymer-Peptide Conjugates Based on Maximin H5 and PEG to Prevent Biofouling of E. coli and P. aeruginosa.

Authors:  Valerie Ortiz-Gómez; Victor D Rodríguez-Ramos; Rafael Maldonado-Hernández; José A González-Feliciano; Eduardo Nicolau
Journal:  ACS Appl Mater Interfaces       Date:  2020-09-30       Impact factor: 9.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.